miR-141 modulates osteoblastic cell proliferation by regulating the target gene of IncRNA H19 and IncRNA H19-derived miR-675

American Journal of Translational Research

Volumn 8, Issue 4, 2016, Pages 1780-1788

  He, Peiheng ^a   Kang, Yan ^a   Huang, Guangxin ^a   Wang, Hua ^a   Xu, Dongliang ^a   Liao, Weiming ^a   Zhang, Ziji ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cell proliferation; LncRNA H19; LncRNA H19 derived miR 675; miR 141; Osteoblasts

Indexed keywords

CASPASE 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MICRORNA; MICRORNA 141; MICRORNA 675; PROTEIN BAX; PROTEIN BCL 2; RNA H19; SOMATOMEDIN B; UNCLASSIFIED DRUG; VASCULOTROPIN;

ABSORPTION SPECTROPHOTOMETRY; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCRNA H19 GENE; MTT ASSAY; OSTEOBLAST; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84964824134     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kansara M, Teng MW, Smyth MJ and Thomas DM. Translational biology of osteosarcoma. Nat Rev Cancer 2014; 14: 722-735
2. Luetke A, Meyers PA, Lewis I and Juergens H. Osteosarcoma treatment -Where do we stand? A state of the art review. Cancer Treat Rev 2013; 40: 523-532
3. Daw NC, Chou AJ, Jaffe N, Rao BN, Billups CA, Rodriguez-Galindo C, Meyers PA and Huh WW. Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review. Br J Cancer 2015; 112: 278-82
4. Ni T, Song WX, Luo J, Haydon RC and He TC. Osteosarcoma Development and Stem Cell Differentiation. Clin Orthop Relat Res 2008; 466: 2114-2130
5. Banwait JK, Ali H and Bastola DK. Enriching miRNA binding site specificity with sequence profile based filtering of 3’-UTR region of mRNA. In: 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops. 2012. pp. 558-563
6. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan RI. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 2012; 72: 1865-1877
7. Xu H, Mei Q, Xiong C and Zhao J. Tumor-suppressing effects of miR-141 in human osteosarcoma. Cell Biochem Biophys 2014; 69: 319-325
8. Itoh T, Nozawa Y and Akao Y. MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem 2009; 284: 19272-19279
9. Ponting CP, Oliver PL and Reik W. Evolution and functions of long noncoding RNAs. Cell 2009; 136: 629-641
10. Jiang X, Yan Y, Hu M, Chen X, Wang Y, Dai Y, Wu D, Zhuang Z and Xia H. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. J Neurosurg 2015; 14: 1-8
11. Atala A. Re: Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. J Urol 2013; 190: 30
12. Ratajczak MZ, Shin DM, Schneider G, Ratajczak J and Kucia M. Parental imprinting regulates insulin-like growth factor signaling: a Rosetta Stone for understanding the biology of pluripotent stem cells, aging and cancerogenesis. Leukemia 2013; 27: 773-779
13. Liu C, Chen Z, Fang J, Xu A, Zhang W and Wang Z. H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation. Tumour Biol 2015; 22: 22
14. Zhuang M, Gao W, Xu J, Wang P and Shu Y. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun 2014; 448: 315-322
15. Zhou X, Ye F, Yin C, Zhuang Y, Yue G and Zhang G. The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric Cancer. Cell Physiol Biochem 2015; 36: 1440-1452
16. Maiti P, Lomakin A, Benedek GB and Bitan G. Despite its role in assembly, methionine 35 is not necessary for amyloid beta-protein toxicity. J Neurochem 2010; 113: 1252-1262
17. Wong ML and Medrano JF. Real-time PCR for mRNA quantitation. Biotechniques 2005; 39: 75-85
18. Shynkar VV, Klymchenko AS, Kunzelmann C, Duportail G, Muller CD, Demchenko AP, Freyssinet JM and Mely Y. Fluorescent biomembrane probe for ratiometric detection of apoptosis. J Am Chem Soc 2007; 129: 2187-2193
19. Yin L, Sun Q, Sun M and Wei DE. Research progress of the interactions between long noncoding RNAs and miRNAs in human cancer. Chinese Clinical Oncology 2014
20. Wang L, Wang Y, Li Z and Yu B. Differential expression of long noncoding ribonucleic acids during osteogenic differentiation of human bone marrow mesenchymal stem cells. Int Orthop 2015; 39: 1013-1019
21. Ying D, Xu Y, Ling D, Yao H, Hong Y, Zhou T and Si J. Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol 2009; 44: 556-561
22. Hu R, Li H, Liu W, Yang L, Tan YF and XH L. Targeting miRNAs in osteoblast differentiation and bone formation. Expert Opin Ther Targets 2010; 14: 1109-1120
23. Yuan Q, Sun L, Li JJ and An CH. Elevated VEGF levels contribute to the pathogenesis of osteoarthritis. BMC Musculoskelet Disord 2014; 15: 1471-2474
24. Robert R. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 2007; 62: 179-213
25. Loeser RF and Shanker G. Autocrine stimulation by insulin-like growth factor 1 and insulinlike growth factor 2 mediates chondrocyte survival in vitro. Arthritis Rheum 2000; 43: 1552-1559
26. Andress DL and Birnbaum RS. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 1992; 267: 22467-22472
27. Maes C, Carmeliet P, Moermans K, Stockmans I, Smets N, Collen D, Bouillon R, Carmeliet G. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 2002; 111: 61-73
28. Choi YC, Yoon S, Jeong Y, Yoon J and Baek K. Regulation of vascular endothelial growth factor signaling by miR-200b. Mol Cells 2011; 32: 77-82
29. Senanayake U, Das S, Vesely P, Alzoughbi W, Fröhlich LF, Chowdhury P, Leuschner I, Hoefler G, Guertl B. miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis 2012; 33: 1014-1021
30. Amanda F, Maria Cristina P, Raffaella D, Paolo M, Daniela Rita Maria S, Murugan K, Giulia S, Alberto B, Gerry M and Eleonora C. Salivary miRNAome profiling uncovers epithelial and proliferative miRNAs with differential expression across dentition stages. Cell Cycle 2011; 10: 3359-3368
31. Hanyin C, Lina Z, Cogdell DE, Hong Z, Schetter AJ, Matti N, Harris CC, Kexin C, Hamilton SR and Wei Z. Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 2011; 6: e17745
32. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD and Patel T. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006; 130: 2113-2129
33. Seki K, Yoshikawa H, Shiiki K, Hamada Y, Akamatsu N and Tasaka K. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma. Cancer Chemother Pharmacol 2000; 45: 199-206.